01 5Blake Cassels & Graydon LLP
01 52419205
01 1GOLIMUMAB
02 4Golimumab
01 1SOLUTION
02 1Solution (Pre-filled Syringe)
03 2Solution (autoinjector)
04 1Solution (pre-filled syringe)
01 52021-08-07
Patent Expiration Date : 2021-08-07
Date Granted : 2010-10-12
Brand Name : SIMPONI
Patent Number : 2419205
Filing Date : 2001-08-07
Strength per Unit : 50 mg / 0.5 ml
Dosage Form : Solution (autoinjector)
Human Or VET : Human
Route of Administration : Subcutaneous
Patent Expiration Date : 2021-08-07
Date Granted : 2010-10-12
Patent Expiration Date : 2021-08-07
Date Granted : 2010-10-12
Brand Name : SIMPONI
Patent Number : 2419205
Filing Date : 2001-08-07
Strength per Unit : 50 mg / 0.5 ml
Dosage Form : Solution (pre-filled syringe)
Human Or VET : Human
Route of Administration : Subcutaneous
Patent Expiration Date : 2021-08-07
Date Granted : 2010-10-12
Patent Expiration Date : 2021-08-07
Date Granted : 2010-10-12
Brand Name : SIMPONI
Patent Number : 2419205
Filing Date : 2001-08-07
Strength per Unit : 100mg / 1.0mL
Dosage Form : Solution (Pre-filled Syringe)
Human Or VET : Human
Route of Administration : Subcutaneous
Patent Expiration Date : 2021-08-07
Date Granted : 2010-10-12
Patent Expiration Date : 2021-08-07
Date Granted : 2010-10-12
Brand Name : SIMPONI
Patent Number : 2419205
Filing Date : 2001-08-07
Strength per Unit : 100 mg / 1.0 mL
Dosage Form : Solution (autoinjector)
Human Or VET : Human
Route of Administration : Subcutaneous
Patent Expiration Date : 2021-08-07
Date Granted : 2010-10-12
Patent Expiration Date : 2021-08-07
Date Granted : 2010-10-12
Brand Name : SIMPONI I.V.
Patent Number : 2419205
Filing Date : 2001-08-07
Strength per Unit : 50 mg / 4.0 mL
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : INTRAVENOUS
Patent Expiration Date : 2021-08-07
Date Granted : 2010-10-12
